Zhenxing Biopharma raised $322M by selling a 19% share of the company to Kaisa Group Holdings.
November 30, 2017 -- Zhenxing Biopharmaceutical & Chemical, a blood plasma company, raised $322 million by selling a 19% share of the company to Kaisa Group Holdings. Kaisa is a China company known mostly for construction, though it also already owns several healthcare companies. It said the investment would provide diversification and immediate revenues. Zhenxing, which operates mainly in Guangdong and Hunan provinces, has a market capitalization of $1.4 billion.
